Pharmacokinetics of a five-day oral dihydroartemisinin monotherapy regimen in patients with uncomplicated falciparum malaria

Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 3, 2008, Pages 158-164

  Le Thi, Diem Thuy ^a,b   Le, Ngoc Hung ^a   Nguyen, Canh Hung ^c   Thi, Danh Phan ^a   Na Bangchang, Kesara ^b  

^a CHO RAY HOSPITAL   (Viet Nam)

^b THAMMASAT UNIVERSITY   (Thailand)

^c Lam Dong II Hospital   (Viet Nam)

Author keywords

Dihydroartemisinin (DHA); Malaria; Monotherapy; Pharmacokinetics

Indexed keywords

ARENCO NV; DIHYDROARTEMISININ; PIPERAQUINE; PRIMAQUINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROQUINGHAOSU;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; MAXIMUM PLASMA CONCENTRATION; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; VIET NAM; BLOOD; CLINICAL TRIAL; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIMALARIALS; AREA UNDER CURVE; ARTEMISININS; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED;

EID: 48849110792     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.23.158     Document Type: Article

References (31)

1. Li, Z. L., Gu, H. M.,Warshurst, D. C. and Peter, W.: Effects of qinghaosu and related compounds in corporation of [G-3H]hypoxanthine by Plasmodium falciparum in vitro. Trans Roy Soc Trop Med Hyg., 77: 522-523 (1983).
2. Hien, T. T. andWhite, N. J.: Qinghaosu. Lancet., 341: 603-608 (1993).
3. Skinner, T. S., Manning, L. S., Johnston, W. A. and Davis, T. M. E.: In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Int J Parasitol., 26: 519-526 (1996).
4. Na-Bangchang, K., Congpuong, K., Ubalee, R., et al.: Pharmacokinetics and ex-vivo antimalarial activity of sera following a single dose of dihydroartemisinin in healthy Thai males. Southeast Asian J Trop Med Public Health., 28: 731-735 (1997).
5. Hung, L. N.: Pharmacokinetics of mefloquine, given alone or in combination with dihydroartemisinin, in patients with uncomplicated falciparum malaria. Ph.D. Thesis, Faculty of Tropical Medicine, Mahidol University., 95-109 (1999).
6. Li, G. Q., Guo, X. B., Fu, L. C., Jian, H. X. and Wang, X. H.: Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg., 88: 5-6 (1994).
7. Lee, I. S. and Hufford, C. D.: Metabolism of antimalarial sesquiterpene lactones. Pharmacol Ther., 48: 345-355 (1990).
8. Batty, K. T., Thu, L. T. A., Davis, T. M. E., et al.: A pharmacokinetic and pharmacodynamic study of intravenous vs. oral artesunate in uncomplicated falciparum malaria. Br J Clin Pharmacol., 45: 123-129 (1998).
9. Olliaro, P. L., Haynes, R. K., Meunier, B. and Yuthavong, Y.: Possible modes of action of the artemisinin-type compounds. Trends in Parasitology., 17: 122-126 (2001).
10. Xu, C., Ding, Y. and Qi, Z.: Efficacy of dihydroartemisinin in treatment of 37 malaria cases. Zhonghua Nei Ke Za Zhi., 36: 187-189 (1997).
11. Looaresuwan, S., Wilairatana, P., Vanijanonta, S., Pitisuttithum, P., Viravan, C. and Kraisintu, K.: Treatment of acute uncomplicated falciparum malaria with oral dihydroartemisinin. Ann Trop Med Parasitol., 90: 21-28 (1996).
12. Ashton, M., Hai, T. N., Si, N. D., Huong, D. X., Huong, N. V., Nieu, N. T. and Conf., L. D.: Artemisinin pharmacokinetics is time-dependent during repeated oral administration in healthy male adults. Drug Metabolism and Disposition., 26: 25-27 (1998c).
13. Ashton, M., Sy, N. D., Gordi, T., et al.: Evidence for time-dependent artemisinin kinetics in adults with uncomplicated malaria. Pharm Pharmacol Lett., 6: 127-130 (1996).
14. Ashton, M., Nguyen, D. S., Nguyen, V. H., Gordi, T., Trinh, N. H., Dinh, X. H., Nguyen, T. N. and Le, D. C.: Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria. Clin Pharmacol Ther., 63: 482-493 (1998a).
15. Alin, M. H., Ashton, M., Kihamia, C. M., et al.: Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of artesunate in falciparum malaria patients. Trans R Soc Trop Med Hyg., 90: 61-65 (1996a).
16. Alin, M. H., Ashton, M., Kihamia, C. M., Mtey, G. J. and Bjorkman, A.: Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria. Br J Clin Pharmacol., 41: 587-592 (1996b).
17. Khanh, N. X., de Vries, P. J., Ha, L. D., van Boxtel, C. J., Koopmans, R. and Kager, P. A.: Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for falciparum malaria. Antimicrob. Agents and Chemother., 43: 690-692 (1999).
18. Warrell, D. A., Molyneux, M. E. and Beales, P. F.: Severe and complicated malaria. Trans R Soc Trop Med Hyg., 84: 1-65 (1990).
19. White, N. J., Looareesuwan, S., Warell, D. A., Bunnag, D. and Harinasuta, T.: Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med., 73: 564-571 (1982).
20. Karbwang, J. and White, N. J.: Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet., 19: 264-279 (1990).
21. Kevin, T. B., Kenneth, F. I., Geoffrey, E., Shane,M. P., James, L. M., Kevin, P. B. and Timothy, M. E. D.: Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes. Br J Pharmacol., 125 159-167 (1998).
22. Ashton, M., Gordi, T., Trinh, N. H., Nguyen, V. H., Nguyen, D. S., Nguyen, T. N., Dinh, X. H., Johansson,M. and Le, D. C.: Artemisinin pharmacokinetics in healthy adults after 250, 500 and 1000 mg single oral doses. Biopharm Drug Dispos., 19: 245-250 (1998b).
23. Wilkinson, G. R. and Shand, D. G.: A physiological approach to hepatic drug clearance (Commentary). Clin Pharmacol Ther., 18: 377-390 (1975).
24. Zhang, S. Q., Hai, T. N., Ilett, K. F., Huong, D. X., David, T. M. E. and Ashton, M.: Multiple dose study of interactions between artesunate and artemisinin in healthy volunteers. Br J Clin Pharmacol., 52: 377-385 (2001).
25. Sidhu, J. S., Ashton, M., Huong, N. V., et al.: Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria. Br J Clin Pharmacol., 45: 347-354 (1998).
26. Molyneux, M. E. S., Looareesuvan, S., Menzies, I. S., Grainger, S. L., Philips, R. E., Wattanagoon, Y., Thompson, R. P. H. and Warrell, D. A.: Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. Am J trop Med Hyg., 40: 470-476 (1989).
27. Pukrittayakamee, S., Looareesuvan, S., Keeratithakul, D., David, T. M. E., et al.: A study of factors affecting the metabolic clearance of quinine in malaria. Eur J Clin Pharm., 52: 487-493 (1997).
28. Li, W. H., Shu, H. L., Xu, G. Y. and Zeng, Y. L.: The binding of qinghaosu (artemisininand its derivatives to plasma protein. Acta Pharmacol Sin., 17: 783-786 (1982).
29. Wanwimolruk, S., Edwards, G., Ward, S. A. and Breckenridge, A. M.: The binding of the antimalarial arteether to human plasma proteins in vitro. J Pharm Pharmacol., 44: 940-942 (1992).
30. Meshnick, S. R., Taylor, T. E. and Kamcandhonwongpaisan, S.: Artemisinin and the antimarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev., 60: 301-315 (1996).
31. Silamut, K. P., Molunto, M. H., David, T. M. E. and White, N. J.: Alpha 1-acid glycoprotein(orosomucoid) and plasma protein binding of quinin in falciparum malaria. Eur J Clin Pharmacol.,32: 311-315 (1991).